CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Trifluridine-Tipiracil

Phase 3
MERCK (MRK)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
MRKPhase 3
✓Completed

Trifluridine-Tipiracil Phase 3 Est. Readout (TroFuse-015)

Trifluridine-Tipiracil
Oct 2026~
CT.gov
Competitive Landscape

0 competitors in Gastroesophageal Cancer

View Full Landscape
Drug Information

Target Indication

Gastroesophageal Cancer

Clinical Trial

NCT06356311

Last updated: 1/6/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.